Tue, 26th Jan 2021 20:34
Jan 26 (Reuters) - AstraZeneca Chief Executive
Pascal Soriot said on Tuesday that the British drugmaker is
working with Oxford University on a vaccine that will target the
South African variant of COVID-19.
"Having said that, we're also working on a vaccine with
Oxford University that will target the variant," Soriot told
Italian daily La Repubblica in an interview https://bit.ly/2KWidAc
published late on Tuesday.
(Reporting by Kanishka Singh in Bengaluru; Editing by Leslie
Adler)
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...
FTSE 100 up 0.5%, FTSE 250 adds 0.4% *
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...
(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Astrazeneca (AZN)